Soy isoflavone supplementation in postmenopausal women: Effects on plasma lipids, antioxidant enzyme activities and bone density

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 46, Issue 3, 2001, Pages 221-226

  Hsu, C S ^a   Shen, W W ^a   Hsueh, Y M ^a   Yeh, S L ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antioxidants; Bone density; Isoflavones; Lipids; Postmenopause; Soy proteins

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; ISOFLAVONE; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CALCANEUS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BONE DENSITY; BREAST; CALCANEUS; CELL DIVISION; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; SOYBEAN PROTEINS;

EID: 0035047714     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dietary phytoestrogens
2. Contested meanings of the menopause
3. Effects of soy isoflavones on atherosclerosis: Potential mechanism
4. International trends in coronary heart disease mortality, morbidity, and risk factors
5. High performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermo-spray mass spectrometric detection
6. Isoflavones, soy-based infant formulas and relevance to endocrine function
7. Overview of proposed mechanisms for the hypocholesterolemic effect of soy
8. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal Rhesus monkey
9. Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits
10. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum
11. Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction
12. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content
13. Dextran sulfate-Mg+2 precipitation procedure for quantitation of high density lipoprotein cholesterol
14. Estimation on the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge
15. Lignan and phytoestrogen excretion in Japanese consuming traditional diet
16. The isoflavones genistein and daidzein in soybean foods from American and Asian diets
17. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
18. The lack of effect of isoflavone on plasma lipid concentrations in ovariectomized cynomolgus monkeys and LDL susceptibility to oxidation
19. Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease
20. Effects of isoflavones on LDL-cholesterol in vitro but not in vivo
21. Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant disease
22. Antioxidant and antipromotional effects of the soybean isoflavone genistein
23. Defining food components as new nutrients
24. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats
25. Environmental estrogens: Effects on cholesterol lowering and bone in the ovariectomized rat
26. Low dosage micronized 17-estradiol prevents bone loss in postmenopausal women
27. Osteoporosis: Pathophysiology, prevention, diagnosis, and treatment
28. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides
29. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells
30. Inhibition of proliferation of estrogen-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen